1. 1- Zandi S, Shamsi Meymandi S, Sabouri Shahrebabak F.Evaluation of quality of life in patients with psoriasis. Dermatology and Cosmetic 2011; 2 (3): 166-173
2- Nasreen S , Ahmed I , Effendi S. Frequency and Magnitude of Anxiety and Depression in Patients with Psoriasis Vulgaris. Journal of the College of Physicians and Surgeons Pakistan 2008, Vol. 18 (7): 397-400.
3- Nabaei B, Safizadeh H, Hallaji Z. Evaluation of quality of life in psoriatic patients and comparison with healthy control. Iran J Dermatol 2002; 5: 15-21(Persian).
4- Sharma S , Bassi R , Singh A . A comparative study of depression and anxiety in psoriasis and other chronic skin diseases. Journal of Pakistan Association of Dermatologists 2011; 21 (4): 235-240.
5- F Chan , KM Ho , AHT Pang . Depression in Hong Kong Chinese patients with psoriasis . Hong Kong J. Dermatol. Venereol. (2009) 17, 69-77.
6- Tousi P, Ebrahimzadeh S, Zahyraldyn AR, Gachkar L. Study of Depression in patients with psoriasis admitted to Bu-Ali and Lukman hospitals in 1380-81. Pajoohandeh Journal. 2004; 8 (6): 9-15.
7- Anshayyh Sh, Kiani A,Yazdani A. Prevalence of depression and anxiety in patients with psoriasis. Skin Disease 2004; 6 (3): 23-1914.
8- Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000 Sep 15;70(5):567-71
9- Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-92
10- Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002 Oct;147(4):736-42.
11- Menter A. The effect of psoriasis on patients' quality of life and improvements associated with alefacept therapy. J Cutan Med Surg. 2004 Dec;8 Suppl 2:20-5.
12- Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D; IDI Multipurpose Psoriasis Research on Vital Experiences study group. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol. 2003 Aug;149(2):318-22.
13- Aqhakhani Nader, Baqhaee Rahim. Psychosocial Problems in Psoriasis Patients Admitted to Hospitals of Medical Sciences Universities of Tehran. Urmia Journal medical science, Vol. 9, No. 3, Autumn 1998, pp. 168-162
14- Behnam B,Taheri R,Sadat Hashemi M,Nesari-Rad Motlagh M.frequency of psychopathological manifestations in psoriatic patients in semnan city , central part of iran.Journal of Fundamentals of Mental Health, Autumn,2010,Vol.12,No.3(47),P.604-11.
15- Gul . EXPERIENCE OF ANXIETY AND DEPRESSION AMONG PSORIASIS PATIENTS. ASIAN JOURNAL OF SOCIAL SCIENCES & HUMANITIES .2102. Vol.1(4) - 051 061
16- Lakshmy S, Balasundaram S, Sarkar S, Audhya M, Subramaniam E. A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis. Indian J Psychol Med. 2015 Oct-Dec;37(4):434-40.
17- Cohen BE, Martires KJ, Ho RS. Psoriasis and the Risk of Depression in the US Population: National Health and Nutrition Examination Survey 2009-2012. JAMA Dermatol. 2016 Jan;152(1):73-9. doi: 10.1001/jamadermatol.2015.3605.
18- Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol. 2016 Mar 30. doi: 10.1111/jdv.13615. [Epub ahead of print]
19- Beck, A.T., Steer, R.A. & Garbin, M.G. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 1988, 8, 77-100.
20- AzKhosh M. The use of psychological tests and clinical diagnosis. Psychotherapy, 2008; 3: 226-224
|